Overview
Short stature due to partial growth hormone receptor (GHR) deficiency is a rare endocrine condition where the body's cells do not respond fully to growth hormone (GH). Growth hormone is a key signal that tells the body to grow, and it works by attaching to a specific protein on cells called the growth hormone receptor. In this condition, the growth hormone receptor does not work as well as it should, but it still has some function — this is why it is called 'partial' deficiency. As a result, children grow more slowly than expected and end up shorter than their peers, but the growth failure is usually less severe than in complete GH receptor deficiency (also known as Laron syndrome). Children with this condition typically have normal or even elevated levels of growth hormone in their blood, but their bodies cannot use it efficiently. They may have low levels of insulin-like growth factor 1 (IGF-1), which is the downstream hormone that actually drives growth in bones and tissues. Common features include short stature that becomes noticeable during childhood, delayed bone maturation, and sometimes a slightly younger-looking facial appearance for their age. The treatment landscape for this condition includes the use of recombinant human growth hormone (rhGH) therapy at higher-than-usual doses, since the body is partially resistant to GH. In some cases, recombinant IGF-1 (mecasermin, brand name Increlex) may be considered. Early diagnosis and treatment can significantly improve final adult height. The condition is sometimes referred to as partial GH insensitivity or partial Laron syndrome.
Key symptoms:
Short stature compared to peers and family membersSlow growth rate during childhoodDelayed bone age on X-rayNormal or high growth hormone levels in blood testsLow IGF-1 levels in the bloodYounger-looking facial features for ageSlightly smaller head size in some casesDelayed puberty in some individualsMild truncal obesityNormal intelligence and cognitive development
Clinical phenotype terms (7)— hover any for plain English
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Short stature due to partial GHR deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Short stature due to partial GHR deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Short stature due to partial GHR deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Short stature due to partial GHR deficiency.
Community
No community posts yet. Be the first to share your experience with Short stature due to partial GHR deficiency.
Start the conversation →Latest news about Short stature due to partial GHR deficiency
No recent news articles for Short stature due to partial GHR deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How certain is the diagnosis of partial GHR deficiency, and should genetic testing be done to confirm it?,What treatment do you recommend — high-dose growth hormone, IGF-1 therapy, or both?,What is the expected improvement in final adult height with treatment?,How often will my child need blood tests and follow-up visits?,Are there any side effects of treatment I should watch for?,Should other family members be tested for the same genetic change?,Are there any clinical trials or newer treatments available for this condition?
Common questions about Short stature due to partial GHR deficiency
What is Short stature due to partial GHR deficiency?
Short stature due to partial growth hormone receptor (GHR) deficiency is a rare endocrine condition where the body's cells do not respond fully to growth hormone (GH). Growth hormone is a key signal that tells the body to grow, and it works by attaching to a specific protein on cells called the growth hormone receptor. In this condition, the growth hormone receptor does not work as well as it should, but it still has some function — this is why it is called 'partial' deficiency. As a result, children grow more slowly than expected and end up shorter than their peers, but the growth failure is
At what age does Short stature due to partial GHR deficiency typically begin?
Typical onset of Short stature due to partial GHR deficiency is childhood. Age of onset can vary across affected individuals.